You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fevipiprant,

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in United States (Fevipiprant)

Terminated
Has Results
  • Asthma
  • Minneapolis, Minnesota
  • +5 more
Oct 7, 2021

COPD Trial in Germany, United Kingdom (QAW039, Placebo)

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Frankfurt, Germany
  • +3 more
Oct 7, 2021

Nasal Polyps Trial in Worldwide (Fevipiprant 150 mg, Fevipiprant 450 mg, Placebo)

Completed
Has Results
  • Nasal Polyps
  • Fevipiprant 150 mg
  • +2 more
  • Irvine, California
  • +24 more
Oct 7, 2021

Renal Insufficiency Trial in Orlando, Grunstadt (QAW039, QAW39A, QAW39A2107)

Completed
  • Renal Insufficiency
  • Orlando, Florida
  • +1 more
Dec 9, 2020

Hepatic Impairment Trial in Anaheim, Orlando (Fevipiprant)

Completed
  • Hepatic Impairment
  • Anaheim, California
  • +1 more
Dec 9, 2020

Asthma, Asthma, Bronchial, Bronchial Asthma Trial (QAW039)

Withdrawn
  • Asthma
  • +4 more
  • (no location specified)
May 12, 2020

Atopic Asthma Trial in Hannover (Blood Sampling)

Completed
  • Atopic Asthma
  • Blood Sampling
  • Hannover, Niedersachsen, Germany
    Fraunhofer ITEM im CRC
Jun 16, 2020

Asthma Trial in Worldwide (Placebo once daily, QAW039 150 mg once daily, QAW039 450 mg once daily)

Terminated
Has Results
  • Asthma
  • Placebo once daily
  • +2 more
  • Newport Beach, California
  • +120 more
Oct 7, 2021

Asthma Trial in Worldwide (QAW039 150 mg, QAW039 450 mg, Placebo)

Terminated
Has Results
  • Asthma
  • QAW039 150 mg
  • +2 more
  • Birmingham, Alabama
  • +347 more
Sep 14, 2020